Predictive Value of Nervous Cell Injury Biomarkers in Moderate-to-Severe Traumatic Brain Injury

Le résumé fourni par la source

BACKGROUND AND OBJECTIVES: Outcome prediction in traumatic brain injury (TBI) guides treatment decisions. Biomarkers such as S100 calcium-binding protein B (S100B), glial fibrillary acidic protein (GFAP), neuron-specific enolase (NSE), and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) have shown prognostication value, but relative effectiveness is unknown. This network meta-analysis (NMA) explored the relative predictive value of these 4 biomarkers for mortality and functional outcomes after moderate/severe TBI. METHODS: Three databases (PubMed, EMBASE, and Cochrane Library) were searched using terms related to TBI, biomarkers, mortality, and functional outcomes (Glasgow Outcome Scale [GOS], GOS-Extended [GOSE]) until June 2024. Primary outcomes were mortality and functional outcomes (GOS/GOSE scores) at 3-12 months after injury. We included studies that provided biomarker levels, sensitivity/specificity values, and outcome measures in adults with moderate/severe TBI. RoB2 and ROBINS-I assessed the risk of bias. Data extraction followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Random-effects models pooled standardized mean difference (SMD), sensitivity, and specificity. Bayesian NMA estimated odds ratios (ORs) and 95% CIs to evaluate indirect comparisons between the biomarkers. RESULTS: = 0%). Earlier sampling periods (<12 hours) were associated with more consistent and reliable results across all biomarkers. NSE had the highest sensitivity for mortality (88%, 77%-93%), and UCH-L1 had the highest specificity (89%, 76%-95%). S100B had the highest sensitivity for unfavorable functional outcomes (74%, 55%-88%), and GFAP had the highest specificity (84%, 71%-91%). With low comparative heterogeneity, NSE had the highest rank probability for mortality prediction while UCH-L1 predicted unfavorable functional outcomes. DISCUSSION: Our findings suggest that S100B, GFAP, NSE, and UCH-L1 have predictive value for mortality and functional outcomes in moderate/severe TBI. NSE was the most effective biomarker for predicting mortality. By contrast, UCH-L1 ranked highest for predicting unfavorable functional outcomes. Further research is needed to standardize protocols for measuring/providing data on biomarkers and to integrate them into predictive models for clinical use.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.